Roche announced that it will invest USD 50 billion into the United States of America in the next five years. These ...

NEW YORK – Impacts from China's volume-based procurement program and other healthcare pricing reforms led to flat Q1 diagnostics revenues year over year for Roche, company executives said Thursday.

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

Around 1,000 of these jobs will be within the company with the others in supporting roles, including construction. The ...

Roche said Tuesday it plans to invest $50 billion in the U.S. over the next five years, creating more than 12,000 new jobs in ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...